Discordance Between Hemoglobin A1c and Continuous Glucose Monitoring due to Hemoglobin Variant: A Case Report of Hb Sitia [HbB c.386C>T (p.Ala129Val)]
AACE Endocrinology and Diabetes · 2026-09
DOI: 10.1016/j.aed.2026.08.010 ↗Kurz gefasst
Fallbericht in der Zeitschrift AACE Endocrinology and Diabetes, 2026-09. Verfasst von Serra Alpözen Yağcı und 2 weiteren Autor:innen. Die Arbeit nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Yağcı, S. A., Uğur, M. C., & Çolak, A. (2026). Discordance Between Hemoglobin A1c and Continuous Glucose Monitoring due to Hemoglobin Variant: A Case Report of Hb Sitia [HbB c.386C>T (p.Ala129Val)]. AACE Endocrinology and Diabetes. https://doi.org/10.1016/j.aed.2026.08.010
Vancouver
Yağcı SA, Uğur MC, Çolak A. Discordance Between Hemoglobin A1c and Continuous Glucose Monitoring due to Hemoglobin Variant: A Case Report of Hb Sitia [HbB c.386C>T (p.Ala129Val)]. AACE Endocrinology and Diabetes. 2026. doi:10.1016/j.aed.2026.08.010
BibTeX
@article{Yac2026,
author = {Yağcı, Serra Alpözen and Uğur, Mehmet Can and Çolak, Ayfer},
title = {Discordance Between Hemoglobin A1c and Continuous Glucose Monitoring due to Hemoglobin Variant: A Case Report of Hb Sitia [HbB c.386C>T (p.Ala129Val)]},
journal = {AACE Endocrinology and Diabetes},
year = {2026},
doi = {10.1016/j.aed.2026.08.010}
}
EUVIMED